GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Krishna Institute of Medical Sciences Ltd

KIMS Ltd Receives Stock Exchange Approval for QIP Share Listing

FUNDRAISE ▲ Positive Development LOW RISK
📅 Filed on BSE: 23 Jun 2026, 01:59 PM IST  ·  BSE ID: 4b1d1c72-0d45-4c36-b1ce-8b364176ac12
View Original BSE Filing (PDF)
💡
In Simple Terms
The company got permission from stock exchanges to list shares it recently sold to big investors.
🤖 AI Summary
  • Stock exchanges approved listing of 1,98,67,549 equity shares via QIP.
  • Shares issued to qualified institutional buyers at Rs. 755 per equity share.
  • Total capital raised through QIP amounts to Rs. 15,000 million.
  • Listing approval received from BSE and NSE for the QIP issuance.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Equity Shares Approved for Listing
1,98,67,549
Issue Price per Equity Share
Rs. 755/-
Total Capital Raised via QIP
Rs. 15,000 million
🏢 How This Affects the Company
📈
Business Impact
The successful QIP enables the company to access growth capital without impacting the existing promoter or public shareholding structure significantly.
💰
Financial Impact
The Rs. 15,000 million raised will bolster the company's balance sheet, providing liquidity for expansion and operational needs.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding this QIP share listing approval.
👤
Who Is Affected
This primarily affects the qualified institutional buyers who subscribed to the QIP shares, as their investment is now listed and tradable.
🔍
Management Signal
The management's successful execution of a large QIP signals a proactive approach to capital raising for strategic growth objectives.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
KIMS FY27 Q1 Results – to assess deployment of QIP funds.
Any future announcements regarding use of raised capital.
Periodic updates on operational expansion funded by QIP.
LOW RISK This is a routine regulatory filing confirming a completed fundraise.
💡 Investor Takeaway
Krishna Institute of Medical Sciences Ltd received approval to list 1,98,67,549 equity shares from its QIP, having raised Rs. 15,000 million at Rs. 755 per share.
⚖️ Strengths & Concerns

✅ Positives

  • Successful completion of Rs. 15,000 million QIP infusion at Rs. 755 per share.
  • Received formal listing approval from both BSE and NSE for the QIP shares.
❓ Frequently Asked Questions
What did Krishna Institute of Medical Sciences Ltd get approval for?
Krishna Institute of Medical Sciences Ltd received approval from BSE and NSE for listing 1,98,67,549 equity shares issued through QIP.
How much capital did KIMS raise through its QIP?
KIMS raised Rs. 15,000 million through the Qualified Institutional Placement (QIP) issuance.
At what price were the QIP shares allotted by KIMS?
The QIP shares were allotted by KIMS at a price of Rs. 755/- per equity share.
How many equity shares are being listed following KIMS' QIP?
1,98,67,549 equity shares are being listed following Krishna Institute of Medical Sciences Ltd's QIP.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.